References
- Wauquier, A., Van Den Broeck, W., Verheyen, J.L., & Janssen, P.A. J. (1978). Eur. J. Pharmacol., 47, 367.
- Tanigawara, Y., et al. (1999). Clin. Pharmacol. Ther., 66, 528.
- Horton, D.A., Bourne, G.T., & Sinythe, M.L. (2003). Chem. Rev., 103, 893.
- Robertson, D.W., et al. (1985). J. Med. Chem., 28, 717.
- Erhardt, P.W., et al. (1989). J. Med. Chem., 32, 1173.
- Vijesh, A.M., et al. (2011). Eur. J. Med. Chem., 46, 3531.
- Kruse, L.I., et al. (1986). J. Med. Chem., 29, 2465.
- Laufer, S., et al. (2010). Bioorg. Med. Chem. Lett., 20, 6671.
- Radziszewski, B. (1882). Chem. Ber., 15, 1493.
- Yanover, D., & Kaftory, M. (2009). Acta Cryst., E65, 711.
- Prabhuswamy, M., Viveka, S., Kumar, S.M., Nagaraja, G.K., & Lokanath, N.K. (2013). Acta Cryst., E69, 1006.
- Saberi, A., et al. (2009). Mol. Cryst. Liq. Cryst., 515, 199.
- Gayathri, P., Thiruvalluvar, A., Saravanan, K., Jayabharathi, J., & Butcher, R.J. (2010). Acta Cryst., E66, 2519.
- Oxford Diffraction. (2009). CrysAlis PRO and CrysAlis RED, Oxford Diffraction Ltd.: Abingdon, Oxfordshire, England.
- Oxford Diffraction. (2009). CrysAlis PRO, Oxford Difraction Ltd.: Abingdon, Oxfordshire, England.
- Sheldrick, G.M. (2008). Acta Cryst., A64, 112.
- Spek, A.L. (1990). Acta Cryst., A46, 34.
- Macrae, C.F., et al. (2008). J. Appl. Cryst., 41, 466.
- Seethalakshmi, T., Puratchikody, A., Lynch, D.E., Kaliannan, P., & Thamotharan, S., (2006). Acta. Cryst., E62, 2803.